key: cord-0845698-yvikpklq
authors: Nemudraia, Anna; Nemudryi, Artem; Buyukyoruk, Murat; Scherffius, Andrew; Zahl, Trevor; Wiegand, Tanner; Pandey, Shishir; Nichols, Joseph; Hall, Laina; McVey, Aidan; Lee, Helen; Wilkinson, Royce; Snyder, Laura; Jones, Joshua; Koutmou, Kristin; Santiago-Frangos, Andrew; Wiedenheft, Blake
title: Sequence-specific capture and concentration of viral RNA by type III CRISPR system enhances diagnostic
date: 2022-04-19
journal: Res Sq
DOI: 10.21203/rs.3.rs-1466718/v1
sha: e41a72e13db2c58c958a54c800a59f79566aaf4d
doc_id: 845698
cord_uid: yvikpklq

Type-III CRISPR-Cas systems have recently been adopted for sequence-specific detection of SARS-CoV-2. Here, we make two major advances that simultaneously limit sample handling and significantly enhance the sensitivity of SARS-CoV-2 RNA detection directly from patient samples. First, we repurpose the type III-A CRISPR complex from Thermus thermophilus (TtCsm) for programmable capture and concentration of specific RNAs from complex mixtures. The target bound TtCsm complex primarily generates two cyclic oligoadenylates (i.e., cA3 and cA4) that allosterically activate ancillary nucleases. To improve sensitivity of the diagnostic, we identify and test several ancillary nucleases (i.e., Can1, Can2, and NucC). We show that Can1 and Can2 are activated by both cA3 and cA4, and that different activators trigger changes in the substrate specificity of these nucleases. Finally, we integrate the type III-A CRISPR RNA-guided capture technique with the Can2 nuclease for 90 fM (5x104 copies/ul) detection of SARS-CoV-2 RNA directly from nasopharyngeal swab samples.

Although qPCR (quantitative polymerase chain reaction) remains the "gold standard" for 35 nucleic acid detection, it requires sophisticated equipment, trained personnel, efficient 36 specimen transport to high-complexity labs, and reliable reporting systems 1 . While the 37 complexity and turnaround times necessary for qPCR are acceptable for many 38 diagnostic applications, the SARS-CoV-2 (Severe Acute Respiratory Syndrome 39 Coronavirus 2) pandemic reveals an urgent need for diagnostics that are easy to 40 distribute, simple to perform, and fast enough to stop transmission of a contagious 41 disease 1 . Although rapid antigen tests and isothermal amplification methods have 42 helped address this need, these and other emerging methods have limitations related to 43 sensitivity, versatility, or specificity 2,3 . 44 CRISPR RNA-guided diagnostics (CRISPR-dx) are a diverse group of nascent 45 technologies that aim to address current limitations by providing a versatile and 46 programmable platform that is sufficiently sensitive for clinical applications and stable 47 enough for distribution 4,5 . The first CRISPR-based viral diagnostic came from Collins 48 and colleagues in 2016, when they demonstrated that Cas9 could be used to 49 discriminate between different variants of the Zika virus 6 . This approach relies on 50 converting viral RNA to DNA using reverse transcriptase, followed by isothermal DNA 51 amplification prior to sequence-based discrimination by Cas9. The exclusive recognition 52 of double-stranded DNA (dsDNA) by Cas9 seemed to be an intrinsic limitation for 53 diagnostic applications that require RNA detection. However, Beisel and colleagues 54 recently developed a creative method that uses the trans-acting CRISPR-RNA 55 (tracrRNA) to capture complementary RNA guides derived from RNA viruses 7 . In this 56 system, the engineered tracrRNA-crRNA hybrid guides Cas9 to a complementary 57 dsDNA reporter. While this approach enables RNA detection, Cas9 is a single turn-over 58 enzyme, which may limit its sensitivity. In contrast to Cas9, target recognition by type V 59 (Cas12-DETECTR) and type VI (Cas13-SHERLOCK) CRISPR-systems activates a 60 multi-turnover non-sequence-specific "collateral nuclease" activity that amplifies the 61 signal by cleaving thousands of reporter molecules for every target bound 8,9 . 62 Like type VI, type III systems also recognize complementary RNA. However, unlike any 63 other CRISPR system, target recognition by type III complexes simultaneously activates 64 polymerase and HD-nuclease domains in the Cas10 subunit 10-12 . The polymerase 65 domain has been estimated to generate ~1000 cyclic oligoadenylates per bound RNA 13 , 66 which trans-activate and allosterically regulate diverse multi-turnover ancillary 67 nucleases that provide defense from invading genetic parasites 14, 15 . This biochemical 68 cascade exponentially amplifies the signal when a type III complex detects target RNA, 69 suggesting that these systems have the potential to enhance the sensitivity of CRISPR-70 based diagnostics. However, initial efforts to implement this approach failed to be 71 sufficiently sensitive for clinical applications without prior amplification of the target 72 RNA [16] [17] [18] . The sensitivity of this first-generation diagnostic was in part limited by the use 73 of Csm6 ancillary nucleases that also degrade the cyclic nucleotide activator [19] [20] [21] [22] [23] . 74 Recently, Malcolm White's lab demonstrated that alternative ancillary nucleases, which 75 efficiently cleave reporters but do not cleave the signaling molecule, can be used to 76 enhance the sensitivity of type III-based diagnostics 24 . 77 Despite innovations leading to new and improved CRISPR-based diagnostics, point-of- 78 care testing requires new strategies that simplify the workflow and increase the 79 sensitivity without prior RNA purification or amplification (e.g., PCR, LAMP, NASB, RPA, 80 etc.). Here, we bring CRISPR-dx closer to a deployable diagnostic by developing a type 81 III CRISPR-based method for sequence-specific capture and concentration of RNA from 82 heterogeneous samples. To improve the sensitivity, we purify several different ancillary 83 nucleases (i.e., Can1, Can2, and NucC), systemically test nuclease activation using a 84 series of purified cyclic oligoadenylate standards (i.e., cA3-cA6), test for ring nuclease 85 activity and determine how cyclic oligoadenylates, as well as metal-preferences impact 86 substrate cleavage activities. We show that the Can1 nuclease from T. thermophilus 87 (TtCan1) and the Can2 ortholog from Archaeoglobi archaeon JdFR-42 (AaCan2) are 88 activated by more than one cyclic nucleotide species (i.e., cA3 and cA4) and that 89 substrate specificity of these nucleases changes according to the bound activator. This 90 observation helps to explain how diverse cyclic nucleotides (i.e., cA3-cA6) produced by a 91 single type III surveillance complex integrate distinct activities from a single effector. (Fig. 1a, Supplementary Fig. 1a) . The beads were concentrated using a 113 magnet, and RNAs were extracted from the bound and unbound fractions. The type III 114 complex captured most of the radiolabeled target RNA (76±5.8%), while non-target 115 RNA primarily remains in the supernatant (Fig. 1b, Supplementary Fig. 1b, c) . To 116 determine if type III CRISPR-based RNA capture and concentration results in the 117 synthesis of more cyclic nucleotides, we mixed Csm-beads with 120 µL of a sample 118 containing SARS-CoV-2 RNA and total RNA extracted from HEK 293T cells (Fig. 1c,   119 see Methods). After concentrating the beads with a magnet, we resuspended the pellet 120 in a buffer containing α-32 P-ATP, allowed the cyclic polymerization to proceed, and 121 analyzed the reactions using thin-layer chromatography (TLC). The type III CRISPR-122 based concentration increases the amount of cA3 and cA4, as compared to the reaction 123 performed without RNA concentration (Fig. 1c, d, Supplementary Fig. 1d) . 124 Previously, we repurposed TtCsm6, a cA4-activated ribonuclease, to generate a real-125 time fluorescent readout for Csm-based RNA detection 16 (Fig. 1e, top) . We reasoned 126 that increased cA4 levels after RNA enrichment will boost the nuclease activity of 127 TtCsm6 and therefore increase the sensitivity of the RNA detection. To test this 128 hypothesis, we titrated 10 8 to 10 5 copies/µL of SARS-CoV-2 N-gene RNA into total RNA 129 extracted from HEK 293T cells, concentrated the target RNA using TtCsm Csm3-D34A , 130 resuspended the beads in a buffer containing ATP, and then transferred the 131 polymerization products to a reaction containing TtCsm6 and a fluorescent RNA 132 reporter (i.e., FAM-RNA-Iowa Black FQ). Csm-based RNA enrichment increased the 133 sensitivity of the assay 100-fold compared to the assay without the pull-down (Fig. 1e) (Fig 2a) . 154 To identify Can1 and Can2 orthologs compatible with the TtCsm complex, we generated 155 profile Hidden Markov models (HMMs) to query publicly available microbial genomes 156 and metagenomes from NCBI and JGI. This analysis identified 204 Can1 and 3,121 157 Can2 proteins. Based on this analysis, we selected TtCan1 and three Can2 orthologs 158 from thermophilic organisms for cloning and expression (Fig. 2b) Fig. 2a-c) . To our surprise, TtCan1 robustly degrades plasmid DNA to 164 ~100 bp fragments in the presence of cA3 and Mn 2+ , while cleavage with cA4 is 165 comparable to the background activity in the absence of an activator (Fig. 2c, (Supplementary Fig. 2e) . Based on the unexpected activation of TtCan1 with cA3, we 171 tested several other substrates and discovered that TtCan1 is a cA4-dependent single-172 stranded RNase (ssRNA) but does not cleave ssDNA (Fig. 2c, Supplementary Fig. 2f , (Fig. 2b) . However, only AaCan2 purified in quantities sufficient for biochemical 179 assays ( Supplementary Fig. 3a, b) . We systematically tested the activities of AaCan2 180 against different substrates with a range of cyclic oligoadenylates (Supplementary Fig.   181 3c, d). Like TtCan1, AaCan2 is also a Mn 2+ -and cA3-dependent dsDNase (Fig. 2d , left 182 gel; Supplementary Fig. 3c) , or a ssRNase when activated with cA4. The ssRNase 183 activity of AaCan2 is supported by either Mn 2+ or Mg 2+ (Fig. 2d, Supplementary Fig.   184 3d). Reproducible cleavage of ssDNA is also detectable for AaCan2, but the activity is 185 Mn 2+ -specific, and robust cleavage requires a higher concentration of cA4 (i.e., 45 nM) 186 ( Fig. 2d, Supplementary Fig. 3d ). Cleavage of ssDNA produces a discrete band 187 suggesting that the enzyme processes ssDNA to a minimal cleavage product or that the 188 activity is sequence-specific ( Fig. 2d; Supplementary Fig. 3d To determine if incorporating TtCan1 or AaCan2 improves sensitivity of the Csm-based 196 RNA detection assay, we screened a library of synthetic RNA reporters designed to 197 identify sequences that might be preferred by these nucleases (Supplementary Table   198 1, Supplementary Fig. 4) . Consistent with our gel-based assays, cA4-activated AaCan2 . 215 Finally, we incorporated AaCan2 into the type III-based detection assay and 216 benchmarked this combination against TtCsm6-based detection (Fig. 2f, g) . The 217 TtCsm6-based assay reliably detects 10 6 copies/µL of target RNA (Fig. 2f) , while 218 AaCan2-based reactions are more sensitive (10 5 copies/µL) (Fig. 2g) . While coupling 219 TtCsm-detection to AaCan2 results in significantly higher sensitivity, it also results in 220 higher background, but this background is only evident in the presence of the TtCsm-221 complex ( Fig. 2f, g) , whereas AaCan2 alone demonstrates very little non-specific 222 cleavage ( Fig. 2e) . This disparity suggests that non-sequence specific activation of the 223 Cas10 polymerase may generate low levels of cA4, which stably activates AaCan2, 224 whereas the ring-nuclease of TtCsm6 rapidly degrades cA4 limiting the background 225 signal. Collectively, these results demonstrate that coupling AaCan2 with TtCsm Csm3-226 D34A provides more sensitive RNA detection. 227 Incorporating cA3-dependent nuclease activity does not provide additional sensitivity of 228 RNA detection 229 While our assay uses cA4-activated collateral cleavage of ssRNA reporters, the 230 TtCsm Csm3-D34A -complex also produces cA3 (Fig. 1d, Supplementary Fig. 1d) . We 231 hypothesized that combining cA3-and cA4-sensing nucleases might enhance the 232 sensitivity of TtCsm-based detection (Fig. 3a) . NucC (Nuclease, CD-NTase associated) 233 endonucleases adopt homotrimeric structures forming a 3-fold symmetric pocket for cA3 234 binding 24,32,33 . Binding cA3 triggers dimerization of NucC homotrimers juxtaposing pair 235 of active sites to cleave DNA 32,33 . We purified three thermophilic NucC orthologs and 236 tested cA3-dependent dsDNA cleavage (Supplementary Fig. 6 ). The NucC from 237 Clostridium tepidum (CtNucC) has the highest dsDNase activity and digests plasmid 238 DNA into 300-400 bp fragments in the presence of cA3 (Fig. 3b, Table 1 ). The lowest 246 concentration of cA3 detected by CtNucC is 0.5 nM, which is 10-fold more sensitive than 247 TtCan1 and 100-fold more sensitive than AaCan2 (Fig. 3c) to ~10 4 copies/μL of viral RNA (Fig. 4a, b and Supplementary Fig. 9b, c) . 268 RNA extraction kits are expensive, time-consuming, and require specialized equipment. 269 To eliminate this step, we tested if the TtCsm complex can capture and concentrate 270 target RNA directly from a nasopharyngeal swab sample without prior RNA extraction. 271 To identify lysis conditions that do not inhibit activity of the TtCsm-complex, we tested 272 10 lysis buffer compositions with varying concentrations of detergents (i.e., Triton X-100 273 or NP-40) and chelators (i.e., EDTA or EGTA) (Supplementary Fig. 9d) . We mixed 283 Finally, to assess the sensitivity of direct SARS-CoV-2 RNA detection in swab samples 284 using type III capture and AaCan2-based fluorescent detection (Fig. 4c) , we used a 285 SARS-CoV-2 positive patient sample (Ct ~13.6) that was 10-fold serially diluted in a 286 negative patient swab sample (Fig. 4d) . In this assay, we used lysis buffer 287 supplemented with 0.05% Triton X-100 and 1 mM EGTA. Csm-based RNA capture 288 assay detects SARS-CoV-2 RNA in unprocessed samples (i.e., no RNA purification) 289 with Ct < 21.2 (Fig. 4d, Supplementary Fig. 9f) , which corresponds to 5x10 4 copies/µL 290 and ~5-fold less sensitive compared to detection performed using purified RNA (Fig. 4b,   291 Supplementary Fig. 9e) . To compare the efficiency of direct detection from lysed 292 nasopharyngeal swab relative to detection from extracted RNA, we used three 293 nasopharyngeal swab samples that previously tested positive for SARS-CoV-2 using 294 RT-qPCR (Supplementary Fig. 9f ). All three samples tested positive using direct 295 detection from nasal swabs, however direct detection from patient samples resulted in a 296 higher signal-to-noise ratio. This difference suggests that further optimization of the lysis 297 conditions may lead to higher sensitivity (Supplementary Fig. 9f) . Table 1 Samples (1 µL) were mixed with 100 mM sodium acetate, pH 5.2 (2 µL) and spotted 1.5 504 cm above the bottom of the TLC plate. The plate was placed inside a 2 L beaker filled to 505 ~0.5 cm with developing solvent (0.2 M ammonium bicarbonate pH 9.3, 70% ethanol and 506 30% water) and capped with aluminum foil. The plate was run for 2 h at room temperature 507 and dried. TLC plate was exposed to a phosphor screen and imaged with Typhoon 508 phosphor imager. Chemically synthesized standards (2µM) were resolved on the same 509 TLC plate and visualized using UV shadowing. 510 To test cA3 and cA4 hydrolysis in the presence of ancillary nuclease, radiolabeled cA3 and 511 cA4 produced above were mixed with nuclease (500 nM) in the reaction buffer and 512 incubated for 1 hour at 55°C. Reaction products were phenol-chloroform extracted and 513 resolved using thin-layer chromatography (TLC) for 45 min as described above. Table 1 ). The R-script used to design these 625 reporters is accessible on GitHub (WiedenheftLab/RNA_reporter_design). RNase-dead Type III CRISPR complex from Thermus thermophilus (e.g., TtCsm Csm3-D34A ) is added to a sample to bind complementary "Target" RNA. The His-tagged complex is concentrated using nickel-derivatized magnetic beads and a magnet. b Sequence-specific RNA enrichment with TtCsm Csm3-D34A complex was tested using 25 nM 32 P 5`-end labeled RNA. Target and non-target RNA fragments were mixed with 125 nM TtCsm Csm3-D34A complex, incubated at 65°C for 20 min prior to concentration of the His-tagged complex with nickel-derivatized magnetic beads. After the pull-down, phenol-chloroform extracted RNAs from the supernatants and the Csm-beads were resolved using UREA-PAGE. c Csm-based direct RNA detection using 3 μL of sample is compared to an assay with an additional RNA capture and concentration step. Magnetic beads decorated with TtCsm Csm3-D34A are added to the sample. After concentrating beads with a magnet, the supernatant is decanted. The pellet is then resuspended in a small volume of the reaction buffer containing ATP to activate polymerase activity of Cas10. Polymerization products (e.g., cA3 and cA4) are used for the downstream detection assays. d TtCsm Csm3-D34A polymerization reactions were performed with α-32 P-ATP as shown in c and products were resolved using thin-layer chromatography (TLC). Black arrow shows migration of solvent in the TLC plate. Bands were annotated using chemically synthesized standards ( Supplementary Fig. 1d ). 3 µL (-RNA capture) or 120 µL (+ RNA capture) of SARS-CoV-2 N-gene RNA (10 10 copies/µL) diluted in total human RNA (293T cells) were used for reactions. e TtCsm6-based fluorescent readout (top panel) is used for detection of cA4 generated by TtCsm Csm3-D34A with (red bars) or without RNA capture step (blue bars) as shown in panel c. SARS-CoV-2 N-gene RNA diluted in total human RNA (HEK 293T cells) was used as a target. Fluorescence was measured with qPCR instrument and normalized to the no target control (NTC, HEK 293T RNA only, dashed line). In each assay, means (n=3) were compared with one-way ANOVA. Pairwise comparisons between target RNA dilutions and NTC were performed using post hoc Dunnett's test. Data are shown as mean ± SD. * p < 0.05; **p < 0.005; ***p<0.001; ****p < 0.0001. Fig. 4) . b Left panel: CtNucC (15 nM) is activated by cA3 (20 nM) and cleaves plasmid DNA into short fragments in 15 min. Right panel: The deep sequencing of DNA fragments generated after 5 min of incubation with CtNucC revealed the preferential cleavage sites (ANNT). The reduced sequencing depth at the cut site is consistent with a cleavage mechanism producing 3'-overhangs that are removed by T4 DNA polymerase when sequencing library is prepared. c CtNucC (300 nM), TtCan1 (300 nM) and AaCan2 (300 nM) cleavage assays with fluorescent dsDNA reporter across eight concentrations of cA3 (shown with colors). Data is shown as mean (center line) of three replicates ± S.E.M. (ribbon). d TtCsm RNA detection assays coupled with AaCan2 (ssRNA reporter), CtNucC (dsDNA reporter) and combination of AaCan2 and CtNucC (both reporters). Reactions were performed using samples with target RNA concentrations ranging from 10 7 to 10 2 copies/µL. Samples were prepared by spiking IVT fragment of SARS-CoV-2 N gene in total RNA of SARS-CoV-2 negative nasal swab. Cleavage of the fluorescent reporter was detected by measuring fluorescence every 10 sec in a real-time PCR instrument. Simple linear regression was used to determine slopes for 3 replicates. See Supplementary Fig. 8 for fluorescent curves used in the analysis. Data were plotted as mean (n = 3) ± S.D. and analyzed with one-way ANOVA. All samples were compared to the non-target RNA control (NTC) using one-tailed post-hoc Dunnett's test. *** p < 0.001; ** p < 0.01; * p < 0.05. a Seventeen SARS-CoV-2 positive (red lines) and six negative (blue lines) RNA samples were tested with TtCsm-AaCan2 detection assay with and without upstream RNA capture. Dots show timepoints that were used to analyze type III detection results. Error bars show mean fluorescence in negative samples (n = 6) ± 2.33 S.D. Reactions that generated signal higher than upper bound of this interval were considered positive for SARS-CoV-2 RNA. b Scatter plot showing distribution of Ct values (N1 CDC primers) of RNA samples tested in a.

Red dots show samples that tested positive in type III detection, blue shows samples that tested negative. c Schematic of TtCsm-based RNA capture assay from nasopharyngeal swab coupled with AaCan2-based fluorescent detection. d Nasopharyngeal swab sample positive for SARS-CoV-2 (RT-qPCR Ct = 13.6) was used to make 10-fold serial dilutions in a negative nasopharyngeal swab (Ct > 40). Total of 120 µL of the sample was used for direct detection with TtCsm-based RNA capture assay depicted in c. Bars show mean values (n = 3) ± S.E.M. of the reaction slopes calculated using simple linear regression ( Supplementary  Fig. 9c ). All slopes were compared to the negative control (NTC) with one-way ANOVA and post-hoc one-tailed Dunnett's test. *** p < 0.001; ** p < 0.01; * p < 0.05.

Rapid Diagnostic Testing for SARS-CoV-2

A Real-World Comparison of SARS-CoV-2 Rapid 708

Antigen Testing versus PCR Testing in Florida

Evaluation of Abbott BinaxNOW Rapid Antigen 711 Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites -Pima County

CRISPR-based diagnostics

Low-Cost Detection of Zika Virus Using Programmable 719 Biomolecular Components

Noncanonical crRNAs derived from host transcripts enable multiplexable 721 RNA detection by Cas9

Nucleic acid detection with CRISPR-Cas13a/C2c2

CRISPR-Cas12a target binding unleashes indiscriminate single-725 stranded DNase activity

A cyclic 727 oligonucleotide signaling pathway in type III CRISPR-Cas systems

Spatiotemporal Control of Type III-A CRISPR-Cas Immunity: Coupling DNA Degradation 731 with the Target RNA Recognition

Type III CRISPR-Cas systems produce cyclic oligoadenylate 733 second messengers

The dynamic interplay of host and viral enzymes in type iii 735 crispr-mediated cyclic nucleotide signalling

Evolutionary and functional classification of the CARF domain 737 superfamily, key sensors in prokaryotic antivirus defense

Non-specific degradation of transcripts promotes plasmid 740 clearance during type III-A CRISPR-Cas immunity

Intrinsic signal amplification by type III CRISPR-Cas systems 743 provides a sequence-specific SARS-CoV-2 diagnostic

SCOPE enables type III CRISPR-Cas diagnostics using flexible 746 targeting and stringent CARF ribonuclease activation

Virus detection via 749 programmable Type III-A CRISPR-Cas systems

Type III-A CRISPR-associated protein Csm6 degrades cyclic hexa-751 adenylate activator using both CARF and HEPN domains

A Type III 754 CRISPR Ancillary Ribonuclease Degrades Its Cyclic Oligoadenylate Activator

Ring 757 nucleases deactivate type III CRISPR ribonucleases by degrading cyclic oligoadenylate

Activation and self-inactivation mechanisms of the cyclic 760 oligoadenylate-dependent CRISPR ribonuclease Csm6

Domain Is a Ring Nuclease Triggering Stepwise cA4 Cleavage with ApA>p Formation 764 Terminating RNase Activity

Specificity and sensitivity of 766 an RNA targeting type III CRISPR complex coupled with a NucC endonuclease effector

RNA-Guided RNA Cleavage by a CRISPR RNA-Cas Protein Complex

Control of 771 cyclic oligoadenylate synthesis in a type III CRISPR system

Structure of Csx1-cOA4 complex reveals the basis of RNA decay in Type 773 III-B CRISPR-Cas

Accelerated RNA detection using tandem CRISPR nucleases

The Card1 nuclease provides defence during type III CRISPR 777 immunity

The CRISPR ancillary effector Can2 is a dual-specificity nuclease 779 potentiating type III CRISPR defence

Structure and mechanism of a Type III CRISPR defence DNA 781 nuclease activated by cyclic oligoadenylate

HORMA Domain Proteins and a Trip13-like ATPase Regulate Bacterial 784 cGAS-like Enzymes to Mediate Bacteriophage Immunity

Structure and Mechanism of a Cyclic Trinucleotide-Activated Bacterial 787

Endonuclease Mediating Bacteriophage Immunity

Heat inactivation of the severe 789 acute respiratory syndrome coronavirus 2

RNA and DNA Targeting by a Reconstituted 792 Thermus thermophilus Type III-A CRISPR-Cas System

Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA 795 processing and RNA detection

Test sensitivity is secondary to frequency and turnaround time for 797 COVID-19 screening

The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a

CBASS Immunity Uses CARF-Related Effectors to Sense 3 0-5 0-and 2 801 0-5 0-Linked Cyclic Oligonucleotide Signals and Protect Bacteria from Phage Infection In 802 Brief

Multiplexed and portable nucleic acid detection platform with 804 Cas13, Cas12a and Csm6

Cd-hit: a fast program for clustering and comparing large sets of 806 protein or nucleotide sequences

MAFFT Multiple Sequence Alignment Software Version 7: 808 Improvements in Performance and Usability

MaxAlign: Maximizing usable data 811 in an alignment

HMMER web server: interactive sequence 813 similarity searching

trimAl: a tool for automated 815 alignment trimming in large-scale phylogenetic analyses

ProtTest 3: fast selection of best-fit 818 models of protein evolution

IQ-TREE 2: New Models and Efficient Methods for Phylogenetic 820 Inference in the Genomic Era

FastTree 2 -Approximately Maximum-Likelihood 825 Trees for Large Alignments

. The optimal fluorescent reporter (top) was determined using RNA library screen in Supplementary Fig. 4 . f,g TtCsm RNA detection assays coupled with TtCsm6-(f) and AaCan2-based (g) readouts were performed using samples with target RNA concentrations ranging from 10 7 to 10 2 copies/µL. Samples were prepared by spiking IVT fragments of SARS-CoV-2 N gene into total RNA extracted from nasopharyngeal swab patient sample negative for SARS-CoV-2. Cleavage of fluorescent RNA reporter was detected by measuring fluorescence every 10 sec in a real-time PCR instrument (left). Data were plotted as mean of 4 replicates. Simple linear regression was used to calculate slopes for linear regions of the curves. Bars show mean values (n = 4) ± S.E.M. (right). Data was analyzed with one-way ANOVA followed by multiple comparisons to NTC sample using onetailed post-hoc Dunnett's test. *** p < 0.001; ** p < 0.01; * p < 0.05.

This is a list of supplementary les associated with this preprint. Click to download.Nemudraiaetal.2022Supplementarywithlinenumbers.pdf